Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characteristics of candidates for allergen immunotherapy.
Ciprandi G, Incorvaia C, Dell'Albani I, Masieri S, Cavaliere C, Puccinelli P, Frati F; Italian Observation on Rhinitis (RINOBIT) Study Group. Ciprandi G, et al. Among authors: masieri s. Allergy Rhinol (Providence). 2013 Summer;4(2):e77-81. doi: 10.2500/ar.2013.4.0061. Allergy Rhinol (Providence). 2013. PMID: 24124641 Free PMC article.
Cypress pollen: an unexpected major sensitizing agent in different regions of Italy.
Sposato B, Liccardi G, Russo M, Folletti I, Siracusa A, Scichilone N, Ventura MT, Rolla G, Raie A, Milanese M, Pio R, Pio A, Scala R, Pareo C, Micucci C, Micheletto C, Billeri L, Musarra A, Cavaliere C, Agolli G, Masieri S, Scalese M, Capitani D. Sposato B, et al. Among authors: masieri s. J Investig Allergol Clin Immunol. 2014;24(1):23-8. J Investig Allergol Clin Immunol. 2014. PMID: 24765877 Free article.
Therapeutic Applications of Capsaicin in Upper Airways.
Cavaliere C, Masieri S, Cavaliere F. Cavaliere C, et al. Among authors: masieri s. Curr Drug Targets. 2018;19(10):1166-1176. doi: 10.2174/1389450118666171117123825. Curr Drug Targets. 2018. PMID: 29149827 Review.
Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe Asthma.
Sposato B, Scalese M, Milanese M, Masieri S, Cavaliere C, Latorre M, Scichilone N, Matucci A, Vultaggio A, Ricci A, Cresti A, Paggiaro PL. Sposato B, et al. Among authors: masieri s. J Investig Allergol Clin Immunol. 2017;27(6):388-391. doi: 10.18176/jiaci.0196. J Investig Allergol Clin Immunol. 2017. PMID: 29199967 Free article. No abstract available.
Factors reducing omalizumab response in severe asthma.
Sposato B, Scalese M, Milanese M, Masieri S, Cavaliere C, Latorre M, Scichilone N, Matucci A, Vultaggio A, Ricci A, Cresti A, Santus P, Perrella A, Paggiaro PL. Sposato B, et al. Among authors: masieri s. Eur J Intern Med. 2018 Jun;52:78-85. doi: 10.1016/j.ejim.2018.01.026. Epub 2018 Feb 1. Eur J Intern Med. 2018. PMID: 29395935
Omalizumab a new prospective: a nasal polyposis.
Cavaliere C, Begvarfaj E, Frati F, Masieri S. Cavaliere C, et al. Among authors: masieri s. J Biol Regul Homeost Agents. 2018 Jan-Feb;32(1):167-169. J Biol Regul Homeost Agents. 2018. PMID: 29504383
95 results